When are CMOs used? ISR reports
While CMOs are currently engaged mainly through tactical outsourcing, this paradigm will shift as more companies begin outsourcing to preferred providers, says ISR report.
Archives for January 19, 2016
Pfizer hits up four biotechs in $46m R&D collaboration strategy
Pfizer has invested $46m in separate collaborations with four R&D companies specialising in developing ADCs, immuno-oncology candidates and gene-therapies.
FAAH inhibitor safety under microscope after Bial drug trial death
FAAH inhibitors will be looked at closely after a volunteer died in a trial of BIA 10-2474 last week, but it is too early to say drugs of this class are unsafe according to a leading expert.
Rx-to-OTC switching: the heart of OTC market, says GBI Research
Drug manufacturers, regulators, and consumers are increasing pressure on pharma companies to make the Rx-to-OTC switch, as non-prescription medications are cheaper and easier to access.
Colorcon sweetens its offering with Paulaur's pharma sugar sphere biz
Colorcon has acquired Paulaur Corporation’s sugar sphere business to help feed pharma’s demand for multiparticulate dosage forms.